Minimalistic Transcaval TAVR for a Patient With a Small Aorta.

Competing Interests: Funding Support and Author Disclosures Dr B.P. O’Neill is a consultant to and receives research support from Edwards Lifesciences. Dr Frisoli is a proctor for Edwards Lifesciences, Abbott, Boston Scientific, and Medtronic. Dr Wang is a consultant for Edwards Lifesciences, Abbott, Neochord, and Boston Scientific; and receives institutional research grant support from Boston Scientific. Dr W. O’Neill has served as a consultant for Abiomed, Edwards Lifesciences, Medtronic, Boston Scientific, Abbott Vascular, and St. Jude Medical; and serves on the board of directors of Neovasc Inc. Dr Villablanca is a consultant for Edwards Lifesciences and Teleflex. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.